Cancer is one of the leading causes of death worldwide, marked by the uncontrolled growth of abnormal cells. What makes it ...
CAR T-cell therapy, considered one of the most promising breakthroughs in cancer treatment, works by harnessing the patient’s own immune system ...
A research team from the Wuhan National Laboratory for Optoelectronics (WNLO) and the School of Optical and Electronic ...
Did you know: Your brain is constantly renewing itself through a process known as phagocytosis, in which cells surround and ...
Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company focused on delivering a new class of innovative immunotherapies for patients with cancer and other incurable diseases, announced today that a late ...
South African Food Review on MSN
Longevity actives: CLR relaunches MPC™ & Phytosan™ NewAge
Two proven longevity skincare actives from CLR have been relaunched: MPC Milk Peptide Complex and Phytosan NewAge, with updated in vivo study results. These skincare actives are for longevity-focused ...
A research team at the University of California San Diego has discovered a novel and promising method of treating arrhythmogenic cardiomyopathy (ACM), a rare inherited heart disease that can strike ...
ACM impedes the heart from pumping blood to the rest of the body, and is a leading cause of sudden cardiac death in young ...
AlphaGenome is a DNA sequence model that advances regulatory variant-effect prediction to understand genome function.
Researchers have developed two innovative tools to help us delve deeper into cell communication, offering spatial insight ...
NuLiv Science, a leading plant-based nutraceutical ingredients company enabling people to lead healthier lives, announced the release of a new preclinical study evaluating the effects of AstraGin(R) , ...
For the first time, researchers have directly visualized how newly formed cellular organelles leave the endoplasmic reticulum (ER) and transition onto microtubule tracks inside living cells. This new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results